Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-24 @ 10:53 PM
Ignite Modification Date: 2025-12-25 @ 8:22 PM
NCT ID: NCT03108469
Description: None
Frequency Threshold: 5
Time Frame: 196 days
Study: NCT03108469
Study Brief: Efficacy and Safety of IONIS-PKKRx for Preventive Treatment of Chronic Migraine
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
IONIS-PKKRx (ISIS 546254) Those randomized to IONIS-PKKRx (ISIS 546254) received subcutaneous injections containing 1.00 mL (200mg/mL) weekly for weeks 1-16. 0 None 0 15 15 15 View
Placebo Those randomized to placebo will receive subcutaneous injections containing 1.00 mL weekly for weeks 1-16. 0 None 2 15 8 15 View
Serious Events(If Any):

Serious Events

Term Type Organ System Vocab View
Cholecystitis NON_SYSTEMATIC_ASSESSMENT Hepatobiliary disorders MedDRA (Unspecified) View
Gastrectomy NON_SYSTEMATIC_ASSESSMENT Surgical and medical procedures MedDRA (Unspecified) View
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Injection site erythema NON_SYSTEMATIC_ASSESSMENT General disorders MedDRA (Unspecified) View
Injection site induration NON_SYSTEMATIC_ASSESSMENT General disorders MedDRA (Unspecified) View
Injection site pain NON_SYSTEMATIC_ASSESSMENT General disorders MedDRA (Unspecified) View
Injection site pruritus NON_SYSTEMATIC_ASSESSMENT General disorders MedDRA (Unspecified) View
Nausea NON_SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA (Unspecified) View
Pain NON_SYSTEMATIC_ASSESSMENT General disorders MedDRA (Unspecified) View
Sinus congestion NON_SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders MedDRA (Unspecified) View